Ignite Creation Date:
2025-12-24 @ 1:32 PM
Ignite Modification Date:
2025-12-30 @ 6:55 PM
Study NCT ID:
NCT05490095
Status:
COMPLETED
Last Update Posted:
2022-08-05
First Post:
2022-08-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Randomized Crossover of SVG101(Dispersible Tab. of Everolimus) and Afinitor 5mg in Healthy Adults
Sponsor:
SoVarGen Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-07-23
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-02-07
Completion Date Type:
ACTUAL
First Submit Date:
2022-08-02
First Submit QC Date:
None
Study First Post Date:
2022-08-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-03
Last Update Post Date:
2022-08-05
Last Update Post Date Type:
ACTUAL